Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-29

Clinical Trial Update: Efficacy, Safety, Preference and Response Duration of Clobex® Spray and Taclonex® Ointment in Psoriasis [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing efficacy, safety, preference, and response duration for Clobex Spray and Taclonex Ointment in plaque psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOBEX (clobetasol propionate)

Snippet

Sponsor: Galderma R&D | Conditions: Plaque Psoriasis | Phase 4 | Status: COMPLETED